Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atossa Therapeutics, Inc. - Common Stock (NQ:ATOS)

0.6268 +0.0467 (+8.05%)
Streaming Delayed Price Updated: 12:28 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,235,330
Open 0.6109
Bid (Size) 0.6236 (300)
Ask (Size) 0.6298 (500)
Prev. Close 0.5801
Today's Range 0.5900 - 0.6307
52wk Range 0.5510 - 1.290
Shares Outstanding 125,785,200
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did ATOS Stock Jump 10% In Pre-Market Today? ↗
The U.S. Food and Drug Administration granted Orphan Drug Designation to its (Z)-Endoxifen therapy for DMD. 
Via Stocktwits
News headline image
Why Are Shares Of Atossa Therapeutics Up Today? ↗
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock is trading higher on Thursday. Here's what investors need to know. 
Via Benzinga

Performance

YTD
-0.6%
-0.6%
1 Month
-13.5%
-13.5%
3 Month
-39.1%
-39.1%
6 Month
-27.9%
-27.9%
1 Year
-27.9%
-27.9%

More News

Read More
Atossa Therapeutics Stock Jumps After FDA Grants Rare Pediatric Status To DMD Drug — Retail Bets On Phase 3 Fast-Track ↗
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
MicroMarvel - Atossa Therapeutics ↗
Via Talk Markets
News headline image
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
Via Benzinga
News headline image
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
Via ACCESS Newswire
News headline image
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
Earnings Scheduled For March 25, 2025 ↗
Via Benzinga
News headline image
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Via Benzinga
News headline image
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
3 Dirt-Cheap Drug Developers With Blockbuster Potential ↗
Via InvestorPlace
News headline image
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025 ↗
Via InvestorPlace
News headline image
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗
Via InvestorPlace
News headline image
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off ↗
Via InvestorPlace
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
Via InvestorPlace
News headline image
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024 ↗
Via InvestorPlace
News headline image
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar ↗
Via InvestorPlace
News headline image
ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 ↗
Via InvestorPlace
News headline image
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market ↗
Via InvestorPlace
News headline image
This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm" ↗
Via Benzinga
News headline image
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
Via ACCESSWIRE
News headline image
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment ↗
Via Benzinga

Frequently Asked Questions

Is Atossa Therapeutics, Inc. - Common Stock publicly traded?
Yes, Atossa Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Atossa Therapeutics, Inc. - Common Stock trade on?
Atossa Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atossa Therapeutics, Inc. - Common Stock?
The ticker symbol for Atossa Therapeutics, Inc. - Common Stock is ATOS on the Nasdaq Stock Market
What is the current price of Atossa Therapeutics, Inc. - Common Stock?
The current price of Atossa Therapeutics, Inc. - Common Stock is 0.6268
When was Atossa Therapeutics, Inc. - Common Stock last traded?
The last trade of Atossa Therapeutics, Inc. - Common Stock was at 01/16/26 12:28 PM ET
What is the market capitalization of Atossa Therapeutics, Inc. - Common Stock?
The market capitalization of Atossa Therapeutics, Inc. - Common Stock is 78.84M
How many shares of Atossa Therapeutics, Inc. - Common Stock are outstanding?
Atossa Therapeutics, Inc. - Common Stock has 79M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.